stock alerts
stock screener
search stocks using your criteria

Site News

Main features: company information, stock markets, stock filters, intraday charts, alerts, portfolio, customized searches (details)
Site update: January 15 2021, at 18:00 PKST
Stock update: January 15 2021.

Recent Financial News in the 'pharma' category

Login or sign up to search news items.

Wednesday, January 13 2021

Pakistan to get Chinese COVID-19 vaccine by early February: Dr Faisal Sultan
January 13, 2021: Special Assistant to the Prime Minister on National Health Services Dr. Faisal Sultan says Pakistan is hopeful to receive the first batch of Chinese COVID-19 vaccine early next month. Interview with Arab News, he said the government intends to begin the process of vaccination within the first quarter of this year. Dr. Faisal Sultan said the government is looking at multiple options and is in touch with all companies whose vaccines have been approved internationally. He said the National Command and Operation Center has started registering frontline health care workers who will be vaccinated in the first phase.
Related news categories: business economic-indicators misc pharma

Monday, January 04 2021

Getz Pharma held webinar on SARS CoV 2-VOC
Lahore- Emerging data shows that the UK COVID-19 variant (called VOC 202012/01) is a new mutation of the virus that has been identified as a particularly concerning strain of the virus by scientists globally as it feared as more transmissible than previous variants. It has also proven to be particularly infectious amongst children. In the wake of this emerging threat, Getz Pharma’s Public Health Line, brought together an esteemed panel of subject experts to shed light on the effectiveness of vaccines against mutations of the virus on January 2nd, 2021 The program was held live at 7 pm Pakistan, 5 pm Qatar, 10 pm Philippines and 8 am USA. This strain is defined by 17 mutations, out of which eight mutations are located in the spike protein and at least three mutations have the potential to change how immunity is affected in terms of the effectiveness of vaccines.
Related news categories: business economic-indicators misc pharma

Thursday, December 31 2020

Macter International to evaluate various inorganic growth and acquisition related opportunities
December 30, 2020 (MLN): The Board of Directors of Macter International Limited, in its meeting held on December 30, 2020, was briefed that various inorganic growth and acquisition-related investment and financing opportunities are potentially available to the company. After deliberation, the Board authorized the company to evaluate these potential opportunities and conduct necessary feasibility studies, engage consultants, valuators, and advisors as may be required from time to time. The Board further authorized the management to enter into non-binding discussions, negotiations, and arrangements and present the same to the Board for their final consideration.
Related news categories: business company-news economic-indicators misc pharma psx stock-exchanges
Related symbols: macter (news stock) helpline: +92-42-3631-4186 (10:30am to 5:30pm)